What You Should Know:
- Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer, a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials.
As part of the agreement, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply Vysioneer's advanced machine-learning techniques to facilitate the drug efficacy assessment process, thereby allowing Pfizer
Read More
Aledade Acquires Curia, Adds More Than 450 New Practices
What You Should Know:
- Aledade today announced the acquisition of Curia, a leader in value-based care analytics using practical applications of artificial intelligence (AI) to optimize the targeting of patient care and engagement programs. The acquisition will enhance Aledade’s ability to extract valuable insights from disparate data sources, provide more accurate predictions using past data, and optimize primary care workflows through cutting-edge AI algorithms.
- In addition, the
Read More
Ascensia Diabetes Care Partners with SNAQ to Support Mealtime Decision-Making
What You Should Know:
- Ascensia Diabetes Care, a global diabetes care company announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes (PWDs).
- As part of the strategic collaboration, Ascensia and SNAQ will integrate their solutions to empower more PWDs to make impactful mealtime decisions, with a goal to improve diabetes management.
Support Mealtime Decision-Making
Read More
AGS Acquires Offshore Patient Access BPO Unit from Availity
What You Should Know:
- AGS Health, a provider for tech-enabled revenue cycle management (RCM) solutions announces the acquisition of the India-based patient access outsourcing business unit of the Florida-based healthcare technology company Availity.
- With more than half of U.S. hospitals anticipating a year of negative margins, achieving full and accurate reimbursement for services has never been more critical. With this expansion, AGS Health is positioned to provide faster, more
Read More
Experian Health Launches AI-Driven Predictive Denials Management
What You Should Know:
- Experian Health launches a new AI-Powered solution, AI Advantage that will help providers recoup the billions in lost dollars due to insurance claim denials.
- These new solutions leverage AI and help healthcare providers prioritize their claims reimbursement process and decrease denials overall, saving time and money across the entire healthcare value chain and ultimately improving care and service for patient consumers.
AI Advantage
One of the top
Read More
FemTech: Samsung Adds Menstrual Cycle Tracking Capabilities to Galaxy Watch5
What You Should Know:
- Samsung Galaxy Watch5 users will soon be able to access temperature-based menstrual cycle tracking through the Cycle Tracking feature. This new capability was developed in partnership with Natural Cycles, a women’s health company and app maker, and marks the first time Natural Cycles’ algorithm has been adapted for a smartwatch.
- The partnership combines Natural Cycles’ fertility technology with Samsung’s BioActive Sensor to give users more detailed
Read More
CARE4 Project Delivers Single Patient Portal with MEDITECH Expanse
What You Should Know:
- MEDITECH today announced the CARE4 project has delivered a single patient portal across acute and ambulatory settings with MEDITECH Expanse.- Since becoming the first Canadian MEDITECH customers to go LIVE with Expanse Ambulatory, the partnership’s goal has been to ensure that all patients associated with their facilities can easily see and manage their health information from a single place. And six months after implementing the portal, partner hospitals –
Read More
Vida Health Expands its Cardiometabolic Capabilities
What You Should Know:
- Vida Health is expanding its solution for chronic conditions by adding the ability to prescribe and deprescribe glucagon-like peptide 1 (GLP-1) agonists for both type 2 diabetes and obesity for appropriate patients. As part of Vida’s value-oriented treatments for cardiometabolic conditions, patients with obesity and diabetes will now be candidates for GLP-1 therapy within the Vida platform.
- With the addition of GLP-1s and other obesity medications in higher acuity
Read More
Veradigm and HealthVerity Partner to Advance Real-World Evidence for Cardiovascular Disease and Diabetes
What You Should Know:
- Today, Veradigm and HealthVerity announced a collaboration to advance research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem.
- The HealthVerity IPGE platform is an integrated technology and
Read More
DarioHealth Integrates Dexcom CGM Data into Diabetes Platform
What You Should Know:
- DarioHealth announced a partnership with Dexcom, the global leader in real-time continuous glucose monitoring (CGM) technology, to integrate its market-leading CGM data into Dario's multi-chronic condition platform.
- Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. This agreement enables the integration
Read More
